NASDAQ NMS - GLOBAL MARKET · GENB
-1.45% · -$0.2300 · Vol 504.0K
Market closed · last close 4:00 PM ET · price as of 19:33:16 ET
Generate Biomedicines Inc

Generate Biomedicines Inc

Biotechnology
$15.64
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is GENB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for GENB are being assembled.
About Generate Biomedicines Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2026
Country
US

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$15.85
Day high
$16.18
Day low
$15.48
Previous close
$15.87
52W high
$17.41
-10.17% from high
52W low
$12.56
64% of range
Market cap
$2B
EPS
$-4.2800
Shares out
128.2M
Volume
504K
VWAP
$15.73
Price history computed in-house
1W
-9.07%
1M
+20.12%
SMA 50 $15.35 · above
SMA 200 $15.35 · above
52W position 64%
Veridion warehouse edge

Warehouse intelligence for GENB.

Veridion Score
44
0: 381: 372: 693: 104: 795: 70
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

GENB insider activity

Generate Biomedicines Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for GENB.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GENB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GENB in this window.
Lobbying spend

GENB lobbying filings, year to date.

Registered lobbying filings matched to Generate Biomedicines Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GENB in this window.
Latest news · GENB
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GENB.
Options
Sovereign unlock shows live options positioning for GENB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.